846 results on '"Nout, Remi A"'
Search Results
52. Late, Persistent, Substantial, Treatment-Related Symptoms After Radiation Therapy (LAPERS): A New Method for Longitudinal Analysis of Late Morbidity—Applied in the EMBRACE Study
53. Multibody dynamic modeling of the behavior of flexible instruments used in cervical cancer brachytherapy
54. HECTOR: multimodal deep learning predicts recurrence risk in endometrial cancer.
55. SO019LBA/#875 Molecular features predicts outcomes in multicentric international study of chemoradiation and MRI based image guided brachytherapy for cervical cancer (EMBRACE): final analysis from bioembrace-I
56. SO006/#55 Regular dilation and/or sexual activity show less risk for vaginal stenosis in cervical cancer patients
57. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review
58. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, -2 and -3 trials
59. Reporting of Late Morbidity After Radiation Therapy in Large Prospective Studies: A Descriptive Review of the Current Status
60. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
61. Importance of Technique, Target Selection, Contouring, Dose Prescription, and Dose-Planning in External Beam Radiation Therapy for Cervical Cancer: Evolution of Practice From EMBRACE-I to II
62. Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study
63. Importance of training in external beam treatment planning for locally advanced cervix cancer: Report from the EMBRACE II dummy run
64. Implementation of state-of-the-art (chemo)radiation for advanced cervix cancer in the Netherlands: A quality improvement program
65. Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative
66. Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis
67. Clinical Behavior and Molecular Landscape of Stage I p53-abnormal Low-Grade Endometrioid Endometrial Carcinomas
68. 127 Impact of Brachytherapy Applicator on Clinical Outcomes in Cervix Cancer: An EMBRACE-I Study Analysis
69. 3408: Ten-year results of the PORTEC-3 trial: adjuvant therapy for women with high-risk endometrial cancer
70. 2706: APTw-CEST MRI for personalized target delineation of glioblastoma: A prospective pilot study.
71. 2293: Acute gastrointestinal toxicity of concurrent chemoradiation in cervix cancer: EMBRACE-II findings
72. 1578: Pareto-optimal margin recipe for robust treatment of cervical cancer with plan-of-the-day IMPT
73. 923: Defining the optimal radiation-induced lymphopenia metric to discern survival in esophageal cancer
74. 890: Impact of cumulative cisplatin-dose on distant metastasis after chemoradiation of cervical cancer
75. 613: Outcomes of a phase II trial of high-dose online-adaptive SBRT for abdominal oligometastases
76. 417: Electromagnetic tracking reveals reconstruction errors in intraoperative TRUS–based prostate HDR-BT
77. 245: Fibrosis and cosmetic outcome after breast conserving therapy with or without oncoplastic surgery
78. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer
79. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
80. Benefit of adaptive CT-based treatment planning in high-dose-rate endorectal brachytherapy for rectal cancer
81. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023
82. The impact of bone marrow sparing on organs at risk dose for cervical cancer: a Pareto front analysis
83. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer
84. Endorectal Brachytherapy Boost After External Beam Radiation Therapy in Elderly or Medically Inoperable Patients With Rectal Cancer: Primary Outcomes of the Phase 1 HERBERT Study
85. Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer
86. Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies
87. In Reply to Murakami et al
88. Abstract 5695: Deep learning risk prediction model of distant recurrence from H&E endometrial cancer slides
89. Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
90. Supplementary Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
91. Supplementary figure 6 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
92. Supplementary Table S2 from Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
93. Table S3 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
94. Supplementary figure 1 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
95. Supplementary Table S5 from Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
96. Figure S1 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
97. Supplementary figure 4 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
98. Supplementary table 2 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
99. Supplementary Figure S2 from Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
100. Figure S4 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.